Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Plos One
|
March 31, 2010
Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret
Srinivas S Rao, Wing-Pui Kong, Chih-Jen Wei, et al.
Vaccine
|
December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trials
Yunda Huang, Shelly T Karuna, Holly Janes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 19, 2019
Adaptive Viral Load Monitoring Frequency to Facilitate Differentiated Care: A Modeling Study From Rakai, Uganda
Victor Ssempijja, Martha Nason, Gertrude Nakigozi, et al.
Journal of Virology
|
September 28, 2007
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection
Christof Geldmacher, Clive Gray, Martha Nason, et al.
The Journal of Infectious Diseases
|
December 23, 2016
Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid
James Pettitt, Elizabeth Higgs, Mosoka Fallah, et al.
Journal of Virology
|
January 20, 2012
HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes
Nicole A Doria-Rose, Mark K Louder, Zhongjia Yang, et al.
The Journal of Infectious Diseases
|
February 26, 2015
Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis
Oliver Laeyendecker, Andrew D Redd, Martha Nason, et al.
Nature Communications
|
June 26, 2020
Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies
David A Garber, Debra R Adams, Patricia Guenthner, et al.
Journal of Immunotoxicology
|
October 3, 2008
Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene inserts
Rebecca L Sheets, Judith Stein, Robert T Bailer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 19, 2024
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine
Dean Follmann, Allyson Mateja, Michael P Fay, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Plos One
|
March 31, 2010
Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret
Srinivas S Rao, Wing-Pui Kong, Chih-Jen Wei, et al.
Vaccine
|
December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trials
Yunda Huang, Shelly T Karuna, Holly Janes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 19, 2019
Adaptive Viral Load Monitoring Frequency to Facilitate Differentiated Care: A Modeling Study From Rakai, Uganda
Victor Ssempijja, Martha Nason, Gertrude Nakigozi, et al.
Journal of Virology
|
September 28, 2007
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection
Christof Geldmacher, Clive Gray, Martha Nason, et al.
The Journal of Infectious Diseases
|
December 23, 2016
Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid
James Pettitt, Elizabeth Higgs, Mosoka Fallah, et al.
Journal of Virology
|
January 20, 2012
HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes
Nicole A Doria-Rose, Mark K Louder, Zhongjia Yang, et al.
The Journal of Infectious Diseases
|
February 26, 2015
Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis
Oliver Laeyendecker, Andrew D Redd, Martha Nason, et al.
Nature Communications
|
June 26, 2020
Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies
David A Garber, Debra R Adams, Patricia Guenthner, et al.
Journal of Immunotoxicology
|
October 3, 2008
Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene inserts
Rebecca L Sheets, Judith Stein, Robert T Bailer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 19, 2024
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine
Dean Follmann, Allyson Mateja, Michael P Fay, et al.
Page
of 8